ArticleTechnical innovations & patient support in radiation oncology2025
New workflow and motion analysis for gastric mucosa-associated lymphoid tissue lymphoma on a 1.5-T MR-Linac.
Article in Technical innovations & patient support in radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We developed and evaluated a multiplane cine magnetic resonance imaging (MRI) workflow for magnetic resonance (MR)-guided online adaptive radiation therapy (MRgOART) for gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Two patients underwent MRgOART using this workflow, which enabled real-time assessments of stomach motion and ensured accurate target coverage within a planning target volume. Our workflow allowed visualization of the stomach with complex intrafractional motion caused by respiration and peristalsis. The total treatment time was clinically acceptable. All fractions satisfied our dose constraints. Our workflow supports precise MRgOART delivery for targets with variable shapes and motion, such as gastric MALT lymphoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.